CXCR2 and hepatocellular carcinoma: A meta-analysis of 4012 patients with solid tumors from 21 different studies found that CXCR2 expression was predictive of poor prognosis of patients with hepatocellular carcinoma, gastric cancer, or esophageal cancer [40].